ArticleEuropean journal of nuclear medicine and molecular imaging2026
Utility of FDG PET/CT for detection of infective endocarditis in pediatric and young adult congenital heart disease.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCongenital heart disease (CHD) patients are at increased risk of developing infective endocarditis, particularly following placement of prosthetic valves, stents, and vascular conduits. As compared to studies of infective endocarditis in adults, there is limited data on use of FDG PET/CT for evaluation of pediatric CHD patients. The primary aim of this study is to determine the value of FDG PET/CT for detecting infective endocarditis in a cohort of pediatric and young adult patients with complex CHD, with a secondary aim of demonstrating the feasibility of obtaining adequate dietary preparation in these complex patients.
methodsSingle center retrospective review of patients undergoing
results67 patients accounted for the 75 examinations meeting inclusion criteria. Median age was 21 (IQR 15-26) years. The most common underlying diagnosis was Tetralogy of Fallot (n = 27). Implanted devices were present in 62/67 patients; 53/67 patients had more than 1 implanted device. RV/PA conduit (n = 48) and Melody valve (n = 27) were the most common implants. 50 of 75 (67%) examinations were positive by FDG PET/CT criteria. Sensitivity was 95.9%; specificity was 88.5%, with an overall accuracy of 93.3%. 73% of examinations had adequate suppression of myocardial FDG uptake.
conclusions
Indexed as
Identifiers
42432135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.